Revisit the hospital policy in the era of COVID-19
- Patient with recent history of dry cough, fever and breathlessness (influenza-like or severe acute respiratory illness) without alternative explanation/diagnosis needs to be managed as COVID-19 unless proved otherwise.
- Suspected COVID-19 patient having fever and recent loss of taste and smell be tested for COVID-19.
- Patient with severe acute respiratory illness of unknown aetiology be tested for COVID-19.
- Patient with bilateral consolidation on chest X-ray or ground glass appearance on chest CT or interstitial oedema on chest ultrasound (not fully explained by volume overload) be tested for COVID-19 in moderate to high risk communities/countries.
- Suspected COVID-19 patients with lymphopenia, high ESR or rise in C-reactive protein and suspected of viral fevers be tested for COVID-19.
- Screening of pregnant women for COVID-19 with rapid testing preferably with Elisa in moderate to high risk communities/countries.
- Screening with rapid testing preferably with Elisa prior to invasive interventions, including operations, in moderate to high risk communities/countries.
- Limit the exposure of hospital staff who are susceptible to develop severe complications of COVID-19.
- Hospitals provide PPE to staff depending upon exposure as per international/national/local guidelines.
- Hospitals implement infection prevention control measures meticulously in context of COVID-19.
© Journal of Patan Academy of Health Sciences
Submission of the manuscript means that the authors agree to assign exclusive copyright to JPAHS. All authors must sign a Copyright Transfer and Author Agreement form upon submission of the manuscript to the Journal. The work shall not be published elsewhere in any language without the written consent of JPAHS. The articles published in this journal are protected by copyright which covers translation rights and the exclusive rights to reproduce and distribute all of the articles printed in the journal.